Erratum: First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data
J Clin Oncol
.
2025 Apr 10;43(11):1398.
doi: 10.1200/JCO-25-00452.
Epub 2025 Mar 7.
Authors
Georgina V Long
,
Evan J Lipson
,
F Stephen Hodi
,
Paolo A Ascierto
,
James Larkin
,
Christopher Lao
,
Jean-Jacques Grob
,
Flavia Ejzykowicz
,
Andriy Moshyk
,
Viviana Garcia-Horton
,
Zheng-Yi Zhou
,
Yiqiao Xin
,
Jennell Palaia
,
Laura McDonald
,
Sarah Keidel
,
Anthony Salvatore
,
Divya Patel
,
Leon A Sakkal
,
Hussein Tawbi
,
Dirk Schadendorf
PMID:
40053890
PMCID:
PMC12333515
DOI:
10.1200/JCO-25-00452
No abstract available
Publication types
Published Erratum